RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia

Fieke W. Hoff; Wendy Hu; Yihua Qiu; Alan S. Gamis; Richard Aplenc; E. Anders Kolb; Todd A. Alonzo; Amina A. Qutub; Eveline S. de Bont; Sophia W. M. Bruggeman; Steven M. Kornblau; Terzah M. Horton

doi:10.1182/blood-2018-99-110730

RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia

Fieke W. Hoff, Wendy Hu, Yihua Qiu, Alan S. Gamis, Richard Aplenc, E. Anders Kolb, Todd A. Alonzo, Amina A. Qutub, Eveline S. de Bont, Sophia W. M. Bruggeman, Steven M. Kornblau, Terzah M. Horton

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Number of pages	3
Journal	Blood
Volume	132
Issue number	Suppl.1
DOIs	https://doi.org/10.1182/blood-2018-99-110730
Publication status	Published - 29-Nov-2018
Event	60th Annual Meeting of the American-Society-of-Hematology (ASH) - San Diego, California, United States Duration: 1-Dec-2018 → 4-Dec-2018

Access to Document

10.1182/blood-2018-99-110730

http://www.bloodjournal.org/content/132/Suppl_1/293?sso-checked=true

Handle.net

Persistent link

Cite this

Hoff, F. W., Hu, W., Qiu, Y., Gamis, A. S., Aplenc, R., Kolb, E. A., Alonzo, T. A., Qutub, A. A., de Bont, E. S., Bruggeman, S. W. M., Kornblau, S. M., & Horton, T. M. (2018). RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia. Blood, 132(Suppl.1). https://doi.org/10.1182/blood-2018-99-110730

@article{bd199a7c522242789675913adea80b2d,

title = "RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia",

author = "Hoff, {Fieke W.} and Wendy Hu and Yihua Qiu and Gamis, {Alan S.} and Richard Aplenc and Kolb, {E. Anders} and Alonzo, {Todd A.} and Qutub, {Amina A.} and {de Bont}, {Eveline S.} and Bruggeman, {Sophia W. M.} and Kornblau, {Steven M.} and Horton, {Terzah M.}",

year = "2018",

month = nov,

day = "29",

doi = "10.1182/blood-2018-99-110730",

language = "English",

volume = "132",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "Suppl.1",

note = "60th Annual Meeting of the American-Society-of-Hematology (ASH) ; Conference date: 01-12-2018 Through 04-12-2018",

}

Hoff, FW, Hu, W, Qiu, Y, Gamis, AS, Aplenc, R, Kolb, EA, Alonzo, TA, Qutub, AA, de Bont, ES , Bruggeman, SWM, Kornblau, SM & Horton, TM 2018, 'RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia', Blood, vol. 132, no. Suppl.1. https://doi.org/10.1182/blood-2018-99-110730

RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia. / Hoff, Fieke W.; Hu, Wendy; Qiu, Yihua et al.
In: Blood, Vol. 132, No. Suppl.1, 29.11.2018.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia

AU - Hoff, Fieke W.

AU - Hu, Wendy

AU - Qiu, Yihua

AU - Gamis, Alan S.

AU - Aplenc, Richard

AU - Kolb, E. Anders

AU - Alonzo, Todd A.

AU - Qutub, Amina A.

AU - de Bont, Eveline S.

AU - Bruggeman, Sophia W. M.

AU - Kornblau, Steven M.

AU - Horton, Terzah M.

PY - 2018/11/29

Y1 - 2018/11/29

U2 - 10.1182/blood-2018-99-110730

DO - 10.1182/blood-2018-99-110730

M3 - Meeting Abstract

SN - 0006-4971

VL - 132

JO - Blood

JF - Blood

IS - Suppl.1

T2 - 60th Annual Meeting of the American-Society-of-Hematology (ASH)

Y2 - 1 December 2018 through 4 December 2018

ER -